Cardionovum

Be up
to date.

Latest press release

Two-year outcomes with the LEGFLOW DCB: primary patency maintained in real world patients.

Marc Bosiers (St. Blasius Hospital, Dendermonde, Belgium) will give an update at LINC today on the results of the REFLOW1 study, which investigated the efficacy of the LEGFLOW® drug-coated balloon (DCB) in TASC C and D femoropopliteal lesions.

Learn more >>

APERTO DCB “superior” for AV fistulae lesions in new RCT.

Professor Dr Qizhuang Jin (Peking University First Hospital Nephrology Department, China) spoke to LINC Today about the recently published results of the first randomised controlled trial (RCT) comparing the APERTO® drug-coated balloon (DCB) with high pressure angioplasty balloon in the treatment of arteriovenous fistulae (AVF) lesions.

Learn more >>

APERTO DCB “promising” for central venous stenosis in haemodialysis patients.

In a Q&A with LINC Today, Michael Lichtenberg, angiologist at Klinikum Hochsauerland GmbH, Arnsberg, Germany, discussed the APERTO® OTW (over-the-wire) drug coated balloon (DCB) currently being trialled in haemodialysis patients with central venous stenosis (CVS) in a bid to improve patency of arteriovenous fistulas (AVFs).

Learn more >>

Cardionovum - first transcontinental China-Europe Webinar on the treatment of complications in arteriovenous access in dialysis patients during COVID-19 pandemic.

Guest from Europe: Prof. Michael Lichtenberg (Germany) & Prof. Matteo Tozzi (Italy).

Video of European guests' speech.

Learn more >>

APERTO OTW® Drug Coated Balloon receives first Chinese NMPA Medical Device Registration Certificate for High Pressure DCB for Vascular Access

APERTO®, our innovative paclitaxel coated balloon for arterio-venous access, has received market approval for China. It is the the first high pressure drug coated balloon available in China to treat obstructive lesions of native Arterio Venous Dialysis Fistulae.

The approval was given based on the statistic results from the solidly designed clinical study in Chinese population:
APERTO AVF RCT CHINA.

Learn more >>

Online Seminar: "CARDIOLOGY CARING in COVID-19 PANDEMICS" China-EU

European Key Opinion Leaders as guests:

  • Prof. Dr. Horst Sievert , Frankfurt, Germany
  • Prof. Dr. Giuseppe Tarantini, Padua, Italy
  • Prof. Dr. Jacques Blacher, Paris, France

Video of European guests' speech.

Learn more >>

Upcoming events

Cardionovum® at PVI 2024

Cardionovum® is pleased to invite you to visit us at booth #20.

Location:

Les salles du Carrousel du Louvre
99 rue de Rivoli
75001 Paris,
France

Date: Dec 12, 2024–Dec 14, 2024

Latest events

Cardionovum® at Deutschen Gesellschaft für Kardiologie (DGK) 2023

Cardionovum® is glad to invite you to visit us at booth #017

Location:

Congress Center Rosengarten Mannheim (CCR)
Rosengartenplatz 2, 68161
Mannheim, Germany

Date: Apr 12, 2023–Apr 16, 2023

Cardionovum® is glad to invite you to attend the scientific session:

Clinical Scenario: DES, BRS & DCB - New Insights

  • Dott. Keeble will disclose his presentation entitled “DCB-alone PCI in De Novo Lesions: Exploring New Frontiers with RESTORE® DCB”

    Monday 5th December at 09:15h
    Hall H

Location:

David Intercontinental Convention Center
12 Kaufman St,
Tel Aviv, 61501 Israel

Date: Dec 05, 2022–Dec 06, 2022

Learn more >>

Cardionovum® at CSC 2022

Cardionovum® is delighted to announce the release of the XLIMIT Randomized Clinical Trial data.

  • Dr. Luca Testa, the PI of the study, will share his findings on the topic of:
    OCT-based analysis of XLIMUS® DES vs. SYNERGY DES

    Thursday 16th November at 17:45h
    SALA MADRID 1-2

Location:

Hotel Riu Plaza España
Calle Gran Vía, 84,
28013, Madrid, Spain

You are welcome to visit us at booth #2

Date: Nov 16, 2022–Nov 17, 2022

Learn more >>

go top